Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Aclaris Therapeutics
(8AT.F) Q1 2025
Earnings
8AT.F
Feb 27
Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.97
-0.65
-0.33
-0.01
Details
Expected EPS
-0.2756589872
Actual EPS
-0.971216
Surprise EPS
-0.7
Surprise Percent
-252.33%
Description
Aclaris Therapeutics (8AT.F) has reported earnings of -0.971216 per share for Q1 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login